Temporal variation in p38-mediated regulation of DUX4 in facioscapulohumeral muscular dystrophy

Rajanikanth Vangipurapu, Jonathan Oliva, Amelia Fox, Francis M Sverdrup · 2024

Read Temporal variation in p38-mediated regulation of DUX4 in facioscapulohumeral muscular dystrophy by Rajanikanth Vangipurapu, Jonathan Oliva, Amelia Fox, Francis M Sverdrup (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11531483.txt.

Description

Facioscapulohumeral muscular dystrophy (FSHD) is a degenerative muscle disease caused by loss of epigenetic silencing and ectopic reactivation of the embryonic double homeobox protein 4 gene (DUX4) in skeletal muscle. The p38 MAP kinase inhibitor losmapimod is currently being tested in FSHD clinical trials due to the finding that p38 inhibition suppresses DUX4 expression in preclinical models.

Catalog record

CREATORRajanikanth Vangipurapu, Jonathan Oliva, Amelia Fox, Francis M Sverdrup
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE47 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11531483

Browse the full library · About the Tower of Babel